project id: TCGA-THCA; case submitter id: TCGA-CE-A483; source center: 23; state: released; a260 a280 ratio: 2.02; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.73; rna integrity number: 8.6; age at index: 34; days to birth: -12768; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1978; age at diagnosis: 12768; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage I; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 457.0; icd 10 code: C73; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: No; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 143; days to sample procurement: 0; initial weight: 360.0; portion submitter id: TCGA-CE-A483-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 100.0;